Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy

The present study describes the development of a good manufacturing practice (GMP)-grade liposomal nanotherapy containing prednisolone phosphate for the treatment of inflammatory diseases. After formulation design, GMP production was commenced which yielded consistent, stable liposomes sized 100 nm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nanomedicine
Autores principales: Lobatto, Mark E., Calcagno, Claudia, Otten, Maarten J., Millon, Antoine, Ramachandran, Sarayu, Paridaans, Maarten P.M., van der Valk, Fleur M., Storm, Gert J., Stroes, Erik S.G., Fayad, Zahi A., Mulder, Willem J.M., Metselaar, Josbert M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495976/
https://ncbi.nlm.nih.gov/pubmed/25791805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2015.02.020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares